Integrated Quantitative Targeted Lipidomics and Proteomics Reveal Unique Fingerprints of Multiple Metabolic Conditions

Abstract

Aberrations in lipid and lipoprotein metabolic pathways can lead to numerous diseases, including cardiovascular disease, diabetes, neurological disorders, and cancer. The integration of quantitative lipid and lipoprotein profiling of human plasma may provide a powerful approach to inform early disease diagnosis and prevention. In this study, we leveraged data-driven quantitative targeted lipidomics and proteomics to identify specific molecular changes associated with different metabolic risk categories, including hyperlipidemic, hypercholesterolemic, hypertriglyceridemic, hyperglycemic, and normolipidemic conditions. Based on the quantitative characterization of serum samples from 146 individuals, we have determined individual lipid species and proteins that were significantly up- or down-regulated relative to the normolipidemic group. Then, we established protein–lipid topological networks for each metabolic category and linked dysregulated proteins and lipids with defined metabolic pathways. To evaluate the differentiating power of integrated lipidomics and proteomics data, we have built an artificial neural network model that simultaneously and accurately categorized the samples from each metabolic risk category based on the determined lipidomics and proteomics profiles. Together, our findings provide new insights into molecular changes associated with metabolic risk conditions, suggest new condition-specific associations between apolipoproteins and lipids, and may inform new biomarker discovery in lipid metabolism-associated disorders.

Serum and urine lipidomic profiles identify biomarkers diagnostic for seropositive and seronegative rheumatoid arthritis

“…It can affect the power of accuracy of lipid biomarker candidates in the validation cohort. As insoluble lipids are transported in association with proteins, protein-lipid connectivity networks provide further insights into lipid and protein constituents unique to metabolic characteristics (37,38). There is a lack of prospective proteomics and lipidomics studies in RA.…”

The Lipidomic Signature of Glioblastoma: A Promising Frontier in Cancer Research

“…Lipidomics quickly became a formal area of study, specifically of lipid pathways, including the qualitative and quantitative study of cellular lipid metabolism. Lipid dysregulation has been demonstrated in a variety of pathologies, such as cardiovascular disease and cancers including breast, prostate, colon, squamous cell cancer, melanoma, and more [ 6 , 7 , 8 , 9 ]. Disrupted lipid homeostasis has been discovered in glioblastoma, with over 500 lipids identified in several glioblastoma subtypes [ 10 ].…”